LightLab Imaging is focused on developing Optical Coherence Tomography (OCT). OCT is a new high-resolution high-speed imaging modality that uses advanced photonics for imaging and tissue characterization. Our mission is to help physicians make earlier and more accurate diagnosis of a wide range of diseases including heart disease and cancer.

OCT has been the subject of intensive, worldwide research efforts and is featured prominently at international scientific and medical conferences. LightLab has developed a strong portfolio of fundamental OCT patents.

LightLab Imaging was founded in February of 1998. The President and CEO is David Kolstad.

LightLab employees include pioneers in the development and application of OCT from MIT, Harvard, Lincoln Laboratory and Carl Zeiss, Inc. Company executives and staff also contribute a strong knowledge of heath care and medical device development with significant experience in device development, manufacturing and marketing with companies such as Hewlett-Packard, Agilent Technologies, Boston Scientific and C.R. Bard.

LightLab Imaging has a strong intellectual property position with technology acquired from MIT, Harvard University, Massachusetts General Hospital, Tufts University, Medtronic, and the Zeiss Foundation, as well as numerous internally developed patents.

A Goodman Company

On July 31st 2002, LightLab Imaging became a subsidiary of Goodman Co. Ltd., a Japanese corporation which has a built a long track record of success in interventional cardiology. Goodman was the first company to sell intravascular ultrasound products in Japan and has developed strong skills in this field which will benefit the commercialization of OCT. Goodman Co. Ltd., has embarked on an aggressive growth strategy that includes building a portfolio of leading products and technologies for clinicians worldwide. The purchase of LightLab Imaging represents another step in this strategy.